Dengue at the time of COVID-19 in the Philippines
DOI:
https://doi.org/10.5365/wpsar.2020.11.2.015References
Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020.
Johns Hopkins University. COVID-19 dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU). 2020. https://coronavirus.jhu.edu/map.html (accessed May 4, 2020.
UP COVID-19 Pandemic Response Team. Preparing for a Post-ECQ Scenario: Analysis and Recommendations University of the Philippines, 2020.
WHO-WPRO. Dengue Situation Updates 2019. 2019.
Wartel TA, Prayitno A, Hadinegoro SRS, et al. Three Decades of Dengue Surveillance in Five Highly Endemic South East Asian Countries:A Descriptive Review. Asia Pacific Journal of Public Health 2017; 29(1): 7-16.
Shepard DS, Undurraga EA, Halasa YA. Economic and Disease Burden of Dengue in Southeast Asia. PLOS Neglected Tropical Diseases 2013; 7(2): e2055.
Shepard DS, Undurraga EA, Halasa YA, Stanaway JD. The global economic burden of dengue: a systematic analysis. The Lancet Infectious Diseases 2016; 16(8): 935-41.
DOH. COVID-19 tracker: Philippines. 2020. https://ncovtracker.doh.gov.ph/.
Eric Lopez R, Kay MT, Christopher JG, et al. Co-infection with Dengue Virus and Pandemic (H1N1) 2009 Virus. Emerging Infectious Disease journal 2010; 16(5): 882.
Silarug N, Foy HM, Kupradinon S, Rojanasuphot S, Nisalak A, Pongsuwant Y. Epidemic of fever of unknown origin in rural Thailand, caused by influenza A (H1N1) and dengue fever. The Southeast Asian journal of tropical medicine and public health 1990; 21(1): 61-7.
Hussain R, Al-Omar I, Memish ZA. The diagnostic challenge of pandemic H1N1 2009 virus in a dengue-endemic region: A case report of combined infection in Jeddah, Kingdom of Saudi Arabia. Journal of Infection and Public Health 2012; 5(2): 199-202.
Downloads
Published
How to Cite
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
When the Licensor is an intergovernmental organization, disputes will be resolved by mediation and arbitration unless otherwise agreed.
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation.
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.